CRISPR Therapeutics AG (CRSP) Earnings Signals & AI Vibe Check
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for CRISPR Therapeutics AG?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
10-Q, CRISPR Therapeutics AG's filing signal
turned positive.
earningsVibe SuperAnalyst™ Verdict:
TURNED POSITIVE
Signal Performance — Stock Price Since Filing
30-Day Change
Pending
from filing date
60-Day Change
Pending
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Continuing Negative
GEMINI
Turned Negative
CLAUDE
Continuing Negative
CHATGPT
Continuing Negative
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does CRISPR Therapeutics AG actually do?
Answer:
CRISPR Therapeutics AG is a biopharmaceutical company pioneering transformative gene-based medicines, with a focus on CRISPR/Cas9 gene editing technology. The company has advanced its lead therapy, CASGEVY, for hemoglobinopathies to regulatory approval in multiple global markets. Its pipeline spans four core franchises: hemoglobinopathies, in vivo approaches targeting liver diseases, CAR T cell therapies for autoimmune indications and oncology, and regenerative medicine for Type 1 diabetes. CRISPR Therapeutics employs both ex vivo and in vivo gene editing strategies, aiming to create potentially curative therapies for serious human diseases.
Question:
What are CRISPR Therapeutics AG's revenue drivers?
Answer:
Revenue is primarily driven by collaboration and license agreements, notably with Vertex Pharmaceuticals, which include upfront payments, milestones, and royalties. Grant revenue also contributes to overall income.
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required